β Scribed by Rishab K. Gupta; Donald L. Morton
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. TA-90 is a tumor-associated antigen first identified in the urine and sera of patients with metastatic melanoma. In the early stages of disease, TA-90 is present in circulating immune complexes (ICs) that may be detected with an antigen specific enzyme-linked immunosorbent assay (EL
This report describes the development and applicability of a tumor-associated-antigenspecific immune complex (IC) detection assay to denote the presence of tumor cells in a cancer host. This assay utilizes a murine monoclonal antibody, AD1 -4OF4, which was produced to a glycoprotein tumor-associated
Twenty-two patients received specific active immunotherapy (TAA vaccine once per month for 3 months), with the duration of follow-up, as of July 1984, ranging from 3 months to 36 months (median, 21 months). Of these, seven had Dukes Bz, seven had Dukes C, and eight had Dukes D lesions. All received
## BACKGROUND. The mechanism behind castration-induced apoptosis in prostate cells is unknown, but data from other species suggest that transforming growth factor β€1 (TGF-β€1) may be involved. METHODS. By using quantitative RT-PCR and immunohistochemistry, expression of TGF-β€1 and its receptors typ
## Abstract ## BACKGROUND: Tumorβassociated differentially expressed geneβ12 (TADGβ12) is a serine protease recently found highly differentially expressed in epithelial ovarian cancer. The goal of this study was to identify potential immunogenic peptides derived from TADGβ12 for immunotherapy of o